Elixinol Global Limited Annual Report 2020

Confirmed new group leadership Renewed board Grew operational e£ciencies Substantial operational and corporate cost reduction program Prompt COVID-19 response Implemented sophisticated e-commerce channels Improved balance sheet, oversubscribed capital raising Successful relaunch of the Elixinol brand along with a new global product line-up Developed key new listings in pharmacy and TV shopping channels Strategy review completed on Hemp Foods Australia Strategy to respond to a changing global regulatory environment Strategically utilise well capitalised, strong balance sheet to accelerate journey to profitability Continued tight cost controls Grow e-commerce channels Use positively shifting regulatory environment for cannabis and hemp to grow in UK and prepare for likely change in US Accelerate Hemp Foods Australia’s success Expand European footprint and enter a new global market of scale Step change R&D and innovation agenda to drive new growth Establish Elixinol as authority in CBD & hemp education Expand of hemp foods product o¡ering to new categories Continued global brand building investment Expand CBD skincare reach Elixiniol CBDmarket entry into Australia Optimise supply chain to reduce COGS/ improve service levels Delivering on Strategic Priorities S TRATEGY AND MARKE T UPDATE “We are excited about what lies ahead in 2021, Elixinol Global is reenergised, the regulatory environment is better than ever and, with a strong balance sheet, we are ready to capture the incredible opportunities in front of us.” Oliver Horn, Global CEO FY2020 FY2021 REENERGISE GROW Think – Learn – Adapt Act – Drive 10 Elixinol Global Limited | Annual Report 2020